Sharh maqola

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)

Ursula Schmidt‐ErfurthDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, AustriaJosé García‐ArumíOphthalmology Department, Universidad Autónoma de Barcelona, Barcelona, SpainFrancesco BandelloDepartment of Ophthalmology, Ospedale San Raffaele, Milan, ItalyKarina M. BergDepartment of Ophthalmology, Oslo University Hospital, Oslo, NorwayUsha ChakravarthySchool of Medicine, Dentistry, and Biomedical Sciences, The Queen's University of Belfast, Belfast, UKBianca S. GerendasDepartment of Ophthalmology and Optometry, Medical University of Vienna, Vienna, AustriaJost B. JonasDepartment of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls University Heidelberg, Mannheim, GermanyMichael LarsenFaculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, DenmarkRamin TadayoniDepartment of Ophthalmology, Hôpital Lariboisière, AP-HP, Université Paris 7 - Sorbonne Paris Cité, Paris, FranceAnat LoewensteinDepartment of Ophthalmology, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel

2017en

ABI

Annotatsiya

Diabetic retinal disease is envisioned to become the plague of the coming decades with a steep increase of worldwide diabetes incidence followed by a substantial rise in retinal disease. Improvements in diagnostic and therapeutic care have to cope with this dilemma in a clinically and socioeconomically efficient manner. Laser treatment has found a less destructive competitor in pharmacological treatments. As a consequence of recent rigorous clinical trials, laser photocoagulation is no longer recommended for the treatment of diabetic macular edema (DME), and anti-vascular endothelial growth factor therapy has emerged as first-line therapy. Steroids have maintained a role in the management of chronically persistent DME. The paradigm shifts in therapy are accompanied by a substantial break-through in diagnostics. The following guidance for the management of DME has been composed from the best updated knowledge of leading experts in Europe and represents another volume in the series of EURETINA recommendations for the management of retinal disease.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1159/000458539

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar